Clinical

Pfizer to back Valneva with €91M investment for phase 3 Lyme disease vaccine trial

Pfizer has Valneva’s back in support of the late-phase development of a vaccine for Lyme disease. Pfizer has agreed to invest €90.5M...

New Eurocine and Redbiotec partnership for Herpes Vaccine

Redbiotec will receive royalty payments on the net sales of the Herpes Simplex Virus Type 2 (HSV-2) vaccine. Sales will be made...

Michigan University and Evgen Pharma to work together on colorectal cancer study

Evgen Pharma and University of Michigan have partnered to evaluate SFX-01, Evgen’s lead asset, on possible anti-tumor effects for colorectal cancer (CRC)....

Covid-19 vaccine by Pfizer deemed effective for children below five

Federal health officials claimed last week that Pfizer’s Covid-19 vaccines, in small doses, seem to be effective and safe for children below...

Galactosemia treatment Gavorestat receives Fast Track and Orphan designation from European Medicines Agency

Applied Therapeutic’s Gavorestat (AT-007) was able to successfully receive both Fast Track designation and orphan medicinal product designation from the European Medicines...

Daiichi and AstraZeneca’s new drug Enhertu a possible different way to battle breast cancer

Nearly a quarter of a century ago the treatment of breast cancer was changed after the inception of a drug called Herceptin....

Adcetris has the potential to be a major player in lymphoma drug market according to Saegen and Takeda

For the treatment of Hodgkin lymphoma, ABVD has been the standard for a decade and a half. ABVD is a combination of...

FDA receives application for Parkinson’s treatment by AbbVie

AbbVie, an American Biopharmaceutical company, has submitted an application to the U.S. Food and Drug Authority (FDA) for a treatment developed for...

Latest news

Zealand Pharma and Iktos collaborate to develop AI Technology for Peptide drug design

Specialists in artificial intelligence for new drug design, Iktos announced a research partnership with Zealand Pharma to...
- Advertisement -

UK’s NICE makes recommendation for Imlifidase by Hansa Biopharmaceutical

With the National Institute for Health and Care Excellence’s (NICE) recommendation for the use of imlifdase, over...

Heart failure drug by Cytokinetics delayed – FDA wants more time to review

The Food and Drug Administration requires more time to study Cytokinetics’ omecamtiv mecarbil following analysis of some...

Must read

Surrounded by controversy, FDA approves Biogen’s Alzheimer’s drug Aduhelm

In the middle of the debate about the Alzheimer’s drug approval, the United States FDA has authorized Aduhelm

Amgen’s KRAS drug gets early FDA approval for lung cancer with specific mutation

On Friday, the United States FDA (Food and Drug Administration) has authorized a medication of Amgen Biopharmaceutical in patients with NSCLC

You might also likeRELATED
Recommended to you

Santhera advances gene therapy for LAMA2 MD through deal with Seal Therapeutics

Santhera Pharmaceuticals and Seal Therapeutics' partnership aims...